EuroIntervention PCRonline - Connecting with the community

EAPCI column

Introducing a new EAPCI programme: the Valve for Life initiative

1. Department of Cardiology, Bern University Hospital, Bern, Switzerland; 2. Medical Clinic I, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany; 3. Department of Cardiology, Bristol Heart Institute, Bristol, United Kingdom


In 2015, the Valve for Life initiative was launched by the EAPCI in order “to improve access to transcatheter valve interventions across Europe”. Like the successful Stent for Life initiative for primary percutaneous coronary interventions, Valve for Life aims to raise the awareness of valvular heart disease in the general population, raise educational standards for healthcare professionals and specialists, help to facilitate access to novel therapies such as transcatheter heart valve (THV) interventions, reduce obstacles to therapy implementation and diminish age and gender discrimination in the access to care.

– OR –